BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li DQ, Wang ZB, Bai J, Zhao J, Wang Y, Hu K, Du YH. Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone. World J Gastroenterol 2004; 10(12): 1722-1725 [PMID: 15188493 DOI: 10.3748/wjg.v10.i12.1722]
URL: https://www.wjgnet.com/1007-9327/full/v10/i12/1722.htm
Number Citing Articles
1
Monserrat Llaguno-Munive, Sebastián León-Zetina, Inés Vazquez-Lopez, María del Pilar Ramos-Godinez, Luis A. Medina, Patricia Garcia-Lopez. Mifepristone as a Potential Therapy to Reduce Angiogenesis and P-Glycoprotein Associated With Glioblastoma Resistance to TemozolomideFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.581814
2
Demian Park, Maryann Haldi, Wen Lin Seng. Zebrafish2011; : 177 doi: 10.1002/9781118102138.ch14
3
Kumi Kawano, Ayami Furuya, Yuri Matsuda, Chisato Kimura, Kotono Yamaguchi, Sakura Wakabayashi, Kotone Taniguchi, Kei-ichi Ozaki, Yoshiyuki Hattori. Preparation of liposomes co-encapsulating doxorubicin and mifepristone for treating multidrug-resistant cancerJournal of Drug Delivery Science and Technology 2023; 85: 104605 doi: 10.1016/j.jddst.2023.104605
4
Sumit Jain, Vijay Rathod, Rameshwar Prajapati, Prajwal P. Nandekar, Abhay T. Sangamwar. Pregnane X Receptor and P-glycoprotein: a connexion for Alzheimer’s disease managementMolecular Diversity 2014; 18(4): 895 doi: 10.1007/s11030-014-9550-6
5
Jianzhong Chen, Jichuang Wang, Jingwei Shao, Yu Gao, Jianguo Xu, Suhong Yu, Zhenhua Liu, Lee Jia. The Unique Pharmacological Characteristics of Mifepristone (RU486): From Terminating Pregnancy to Preventing Cancer MetastasisMedicinal Research Reviews 2014; 34(5): 979 doi: 10.1002/med.21311
6
Angelina Sampson, Brian G. Peterson, Kee W. Tan, Surtaj H. Iram. Doxorubicin as a fluorescent reporter identifies novel MRP1 (ABCC1) inhibitors missed by calcein-based high content screening of anticancer agentsBiomedicine & Pharmacotherapy 2019; 118: 109289 doi: 10.1016/j.biopha.2019.109289
7
Jose J.G. Marin, Rocio I.R. Macias, Elisa Herraez, Elisa Lozano, Marta R. Romero, Silvia Di Giacomo, Thomas Efferth, Oscar Briz. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy2020; : 197 doi: 10.1016/B978-0-12-816434-1.00007-3
8
Z. Dostál, P. Kosina, P. Mlejnek, K. Kikalová, M. Modrianský. Mifepristone potentiates etoposide toxicity in Hep G2 cells by modulating drug transportToxicology in Vitro 2019; 54: 33 doi: 10.1016/j.tiv.2018.09.005
9
Sven Marcel Stefan, Michael Wiese. Small‐molecule inhibitors of multidrug resistance‐associated protein 1 and related processes: A historic approach and recent advancesMedicinal Research Reviews 2019; 39(1): 176 doi: 10.1002/med.21510
10
Katja Silbermann, Sven Marcel Stefan, Randa Elshawadfy, Vigneshwaran Namasivayam, Michael Wiese. Identification of Thienopyrimidine Scaffold as an Inhibitor of the ABC Transport Protein ABCC1 (MRP1) and Related Transporters Using a Combined Virtual Screening ApproachJournal of Medicinal Chemistry 2019; 62(9): 4383 doi: 10.1021/acs.jmedchem.8b01821
11
Marina Leite, Raquel Seruca, Jorge M. Gonçalves. Hereditary Gastric and Breast Cancer Syndrome2023; : 281 doi: 10.1007/978-3-031-21317-5_20
12
Shuai Wang, Wujun Chen, Hualong Yu, Zhengming Song, Qian Li, Xin Shen, Yudong Wu, Lei Zhu, Qingxia Ma, Dongming Xing. lncRNA ROR Promotes Gastric Cancer Drug ResistanceCancer Control 2020; 27(1): 107327482090469 doi: 10.1177/1073274820904694
13
Giulia Cossu, Marc Levivier, Roy Thomas Daniel, Mahmoud Messerer. The Role of Mifepristone in Meningiomas Management: A Systematic Review of the LiteratureBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/267831
14
Michael Wiese, Sven Marcel Stefan. The A‐B‐C of small‐molecule ABC transport protein modulators: From inhibition to activation—a case study of multidrug resistance‐associated protein 1 (ABCC1)Medicinal Research Reviews 2019; 39(6): 2031 doi: 10.1002/med.21573